Hospital pharmacist and clinical pharmacologist Rob Aarnoutse is appointed as professor in ‘Translation pharmacology of antimicrobial agents, in particular drugs for tuberculosis’ at Radboud University / Radboudumc, starting 16 November 2020.
Rob Aarnoutse will focus his professorship on optimization of drug treatment of tuberculosis (TB), which is the leading cause of death due to an infectious disease worldwide. Each year 1.5 million people die from this disease. His research line extends from preclinical (molecular) pharmacological research to clinical pharmacological work, pharmacokinetic substudies in larger clinical trials, and research on dose optimization in clinical practice (‘molecule to man’). In order to establish this translational and application-oriented research line, he developed a sustainable network with partners in Radboudumc, elsewhere in The Netherlands and Europe, and in lndonesia, Tanzania and South Africa. He coached 12 PhD students as co-supervisor (co-promotor) and is (co)author of 170 international scientific publications.
Rob Aarnoutse studied Pharmacy in Utrecht and was trained as hospital pharmacist at the Albert Schweitzer hospital in Dordrecht, The Netherlands. Since 1999 he has been working at Radboudumc. In 2003 he obtained a PhD title based on his thesis ‘Application of pharmacokinetics to improve antiretroviral treatment’. Besides his research activities, he is actively involved in patient care as hospital pharmacist, dedicated as trainer for hospital pharmacy trainees, and trainer for clinical pharmacology at Radboudumc. Internationally he is member of the chief investigators group of the PanACEA TB research consortium, initiated the leading annual meeting in the TB pharmacology field, and started several international proficiency testing programmes for measurement of drugs in blood.
R.E. Aarnoutse, PharmD PhD, appointed as professor in ‘Translation pharmacology of antimicrobial agents, in particular drugs for tuberculosis’. Appointment on 16 November 2020, for a period of 5 years.